Updates are available Correction dated 2023-05-30
Click to view Correction: https://doi.org/10.1186/s13024-023-00629-0
-
Authors
Sampognaro, Paul J.
Arya, Shruti
Knudsen, Giselle M.
Gunderson, Emma L.
Sandoval-Perez, Angelica
Hodul, Molly
Bowles, Kathryn
Craik, Charles S.
Jacobson, Matthew P.
Kao, Aimee W. http://orcid.org/0000-0002-7686-7968
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K08NS121519)
American Academy of Neurology (Richard Olney Clinician Scientist Development Award)
National Institutes of Health (U54 NS123746-01, RF1AG068125, R01NS095257, R01AG057342, R01AG059052, U54NS123985)
BrightFocus Foundation (A2021021S)
National Institute of Aging (R01AG059052)
Larry Berkelhammer Foundation
Paul G. Allen Family Foundation
Tau Consortium
Parkinson's Disease Foundation
Glenn Foundation for Aging Research
- License Information
-
More Information
Article History
Received: 29 December 2022
Accepted: 21 April 2023
First Online: 2 May 2023
Change Date: 30 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13024-023-00629-0
Declarations
:
: Not Applicable.
: All authors have reviewed the final manuscript and consent to publication.
: A.W.K. and M.P.J. are Scientific Advisory Board members, and M.P.J. is a founder of Nine Square Therapeutics. C.S.C. is a founder, and G.M.K. is an employee of Alaunus Biosciences. Authors declare that they have no conflicts of interest or competing interests.
